# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 121-130 of 626 results.
Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma
Status: Not yet recruiting
Last Changed: May 24, 2019
First Received: May 22, 2019
Disease(s): Ovarian Cancer
Intervention(s): Intraperitoneal (IP) nivolumab infusion
Locations: Hospices Civils de Lyon, Lyon, France
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
Status: Recruiting
Last Changed: Mar 29, 2018
First Received: Jun 15, 2017
Disease(s): Ovarian Cancer, Fallopian Tube Cancer
Intervention(s): Vinorelbine
Locations: Peter MacCallum Cancer Centre, Melbourne, Australia
National University Hospital, Singapore, Singapore
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Status: Not yet recruiting
Last Changed: May 23, 2019
First Received: Dec 11, 2018
Disease(s): Ovarian Cancer
Intervention(s): cisplatin
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
Status: Recruiting
Last Changed: Jul 17, 2019
First Received: Oct 25, 2017
Disease(s): Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
Intervention(s): HIPEC, Carboplatin, Paclitaxel
Locations: The University of Kansas Cancer Center, Kansas City, Kansas, United States
Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Jan 08, 2019
First Received: Aug 15, 2018
Disease(s): Recurrent Ovarian Cancer
Intervention(s): ChemoID assay, Chemotherapy
Locations: Univeristy of Mississippi Medical Center, Jackson, Mississippi, United States
Charleston Area Medical Center, Charleston, West Virginia, United States
Edwards Comprehensive Cancer Center - Cabell Huntington Hospital, Huntington, West Virginia, United States
Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Aug 28, 2019
First Received: Oct 07, 2014
Disease(s): Ovarian Cancer Stage III, Ovarian Cancer Stage IV
Intervention(s): PET/CT
Locations: Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
Mater Health Services, South Brisbane, Queensland, Australia
Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Jul 11, 2019
Disease(s): Epithelial Ovarian Cancer, Relapse
Intervention(s): Bevacizumab (FKB238), Olaparib and Durvalumab (MEDI 4736) combination
Locations: Institut Bergonié, Bordeaux, France
Centre Oscar Lambret, Lille, France
Centre Léon Bérard, Lyon, France
Centre Hospitalier Lyon Sud, Lyon, France
ICM Val d'Aurelle, Montpellier, France
... and 5 other locations.
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Status: Recruiting
Last Changed: Sep 12, 2018
First Received: Sep 12, 2018
Disease(s): Breast Cancers, Ovarian Cancers
Intervention(s): Questionnaires
Locations: Institut Paoli-Calmettes, Marseille, France
The INFLUENCE of Cytoreduction on PRO in EOC
Status: Not yet recruiting
Last Changed: Feb 18, 2020
First Received: Aug 31, 2017
Disease(s): Epithelial Ovarian Cancer
Locations: Haukeland University Hospital, Bergen, Norway
Sørlandet sykehus HF, Kristiansand, Norway
Stavanger University Hospital, Stavanger, Norway
Fluid Balance During Surgery for Ovarian Cancer
Status: Recruiting
Last Changed: Dec 30, 2016
First Received: Dec 30, 2016
Disease(s): Ovarian Neoplasm, Fluid Therapy
Intervention(s): Cytoreductive surgery
Locations: Dept. of Anaesthesiology and Intensive Care Medicine, University of Bonn, Bonn, Germany